ClinicalTrials.gov
ClinicalTrials.gov Menu

Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00632268
Recruitment Status : Completed
First Posted : March 10, 2008
Last Update Posted : August 21, 2013
Sponsor:
Collaborators:
National Cheng-Kung University Hospital
Taipei Veterans General Hospital, Taiwan
Information provided by (Responsible Party):
National Taiwan University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : December 2012